01 2BioSyent Pharma Inc..
02 12Pfizer Consumer Healthcare, a division of Pfizer Canada Inc
01 12570474
02 122764740
03 12955557
01 2ACETAMINOPHEN | IBUPROFEN SODIUM DIHYDRATE
02 12IBUPROFEN SODIUM DIHYDRATE
01 2SOLUTION
02 12TABLET
01 12025-07-07
02 122030-06-21
03 12035-07-17
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE & MIGRAINE PAIN
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE & MIGRAINE PAIN
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE&MIGRAINE PAIN EXTRA STRENGTH CAPLET
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE CAPLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE TABLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE EXTRA STRENGTH
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL MIGRAINE TABLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL MIGRAINE EXTRA STRENGHT
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL MIGRAINE CAPLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Brand Name : ADVIL HEADACHE & MIGRAINE CAPLETS
Patent Number : 2764740
Filing Date : 2010-06-21
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-21
Date Granted : 2015-09-01
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
